Global
Colposcopy Market Research Report: Instrument Type (Optical Colposcope, Digital
Colposcope), Instrument Portability (Portable, Fixed, Handheld), Application
(Cancer Screening, Examinations), Magnification Type, End-User – Global
Forecast Till 2023
Market
Scenario
A colposcope is basically a surgical
instrument similar to an electric microscope with a source of light that allows
gynecologists to examine the vagina and cervix more clearly and under proper
magnification. The rising prevalence of cervical cancer around the globe is the
primary factor driving the growth of the colposcopy market.
For instance, according to the World Health
Organization (WHO) in 2017, cervical cancer is the second most reason for the
death of women worldwide. Currently, awareness programmes are conducted by
numerous NGOs focusing on health-related issues in women such as cervical
cancer which will increase the demand for colposcopes.
The Global Colposcopy Market is expected to gain
prominence over the forecast period (2018–2023). It is estimated that the
global colposcopy market is expected to register a CAGR of ~6.8% during the
forecast period, 2018–2023.
Despite these drivers, factors such as high
installation cost of this device and lack of skilled clinical users to operate
colposcopes are likely to restrain the growth of the market.
Company
Profiles
- Carl Zeiss
- Olympus Corporation
- Danaher Corporation
- Philips Healthcare
- CooperSurgical
- McKesson Corporation
- DYSIS Medical
- Atmos
- Alliton
- Seliga Microscopes
- Karl Kaps
- Bovie Medical
Segmentation
The global
colposcopy market is segmented on the basis of instrument type, instrument
portability, application, and end-users.
On the basis
of instrument type, the market is classified into optical colposcopes and
digital colposcopes.
On the basis
of instrument portability, the market is classified into portable, fixed, and
handheld.
On the basis
of application, the market is classified as cervical cancer screening, physical
examinations, and others.
On the basis
of magnification type, the market is classified into fixed magnification and
variable magnification
On the basis
of end-user, the market is classified into hospitals, clinics, diagnostic
centers, and others.
Geographically,
the market has been segmented into the Americas, Europe, Asia-Pacific, and the
Middle East and Africa. The American colposcopy market is further segmented
into North America and South America. North America is further classified as
the US and Canada.
The European
colposcopy market is segmented into Western Europe and Eastern Europe. Western
Europe is further classified as Germany, France, the UK, Italy, Spain, and the
Rest of Western Europe.
The colposcopy
market in Asia-Pacific is segmented into Japan, China, India, the Republic of
Korea, Australia, and the Rest of Asia-Pacific.
The Middle
Eastern and African colposcopy market is segmented into the Middle East and
Africa.
Regional
Market Summary
Asia-Pacific
is the fastest growing region in the market owing to the increasing cases of
cervical cancer in the region, growing demand for cervical cancer screening,
and rising healthcare expenditure in Asian countries. Additionally, according
to a study published in the World Health Organization (WHO) in 2017, every year
cervical cancer kills more than 250000 women, and 85% of these deaths occur in
low- and middle-income countries. Furthermore, the rapid development of
economies and increasing healthcare expenditure have fuelled the growth of the
market.
The Americas
is likely to dominate the global colposcopy market owing to
technological advancements in colposcopes such as high-quality video and
improved accuracy in detection. For instance, the American Cancer Society in
2018, estimated about 13,240 new cases of invasive cervical cancer to be
diagnosed in the US with nearly 4,170 women dying from cervical cancer.
Furthermore, continuous development of advanced colposcopy by manufacturers in
the region contributes to the market growth.
Europe is
likely to hold the second position in the global colposcopy market. It is
expected that the favorable reimbursement scenario is responsible for the
ambient growth in this region. Additionally, according to the Cancer Research
UK in 2017, more than 3000 new cases of cervical cancer are diagnosed in the UK
each year.
The Middle
East and Africa accounts for the lowest market share in the global colposcopy
market owing to the lack of awareness regarding cervical cancer in the MEA
region.
Browse more
Medical Device Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report
No comments:
Post a Comment